The latest CDSCO Drug Alert highlights 159 NSQ drug samples and one spurious medicine.
The CDSCO (Central Drug Standard Control) issued its latest drug report in May 2026. In the CDSCO Drug Alert, they revealed that 159 drug samples failed to meet basic laboratory standards and were flagged as Not of Standard Quality (NSQ). And one of the medicines was tagged as a spurious drug during their monthly daily routine surveillance. These monthly reports highlight the work of regulators who monitor medicines and ensure they meet quality standards for prescription to the general public.
What was revealed in the CDSCO Drug Alert?
Every month, CDSCO conducts safety surveillance on medicines to be introduced into the Indian pharmaceutical market. During the May 2026 quality check, it was revealed that 159 of the drug samples were Not of Standard Quality(NSQ). Out of all the medicines, 46 samples were declared NSQ by central drug laboratories and 113 by state drug testing laboratories. These batches of medicine failed basic laboratory testing. Moreover, one of the medicines found in Assam was labeled spurious. The state regulatory machinery has initiated an investigation under the Drugs and Cosmetics Act to trace the supply chain.
These results are from the CDSCO routine surveillance, where medicines are collected as samples from various parts of the country and then undergo quality testing to verify the standards of medicines available on the market.
The meaning of NOT OF STANDARD QUALITY (NSQ)
When a particular batch of medicine fails to meet the basic quality standard, it is flagged as NSQ. It simply means that this batch of the medicine fails to meet specific pharmacopeial parameters such as dissolution profiles, assay limits, or basic sterility requirements.
An NSQ tag doesn’t mean the medicine is toxic or unsafe for the public; it indicates that a batch tested by regulators was found to be of non-standard quality. Further investigation is carried out, issuing product recalls and initiating Corrective and Preventive Actions (CAPA) on the manufacturing line.
The difference between NSQ Drugs and Spurious Drugs
NSQ drugs are usually good products, but the tested batch was found to be faulty because it did not meet regulatory standards. Spurious Drugs, on the other hand, is a scam involving various medicines and companies. According to the Act, 1940 (Section 17B). A drug is legally “spurious” if it is manufactured under a name belonging to another drug, if it substitutes for another drug, or if it falsely claims to be the product of a manufacturer that didn’t actually produce it.
In the latest CDSCO Drug Alert, only one of the collected samples was found to be spurious out of 159. Though it is not good news, it shows that the regulatory officials are doing their work in building a better and safer pharmaceutical ecology in India.
The Importance of Monthly Drug Alerts
Monthly drug alerts are a crucial part of the health ecosystem. It helps to keep the pharmaceutical quality up to standard. Continuous testing will keep a check on batches of medicines released to the market for consumption.
These reports also enforce Good Manufacturing Practices, Quality Assurance, and Quality Control in India’s pharmaceutical industry. It also creates transparency for the common people so that they can rely on and trust the medicines they consume every day.
Key Takeaway
The reveal of the May 2026 CDSCO Drug Alert shows that the safety checks are being conducted periodically by the officials. It also reveals the importance of regular quality checks through the standard protocol for the common public’s health.
While the reports found 159 Not of Standard Quality medicines, we should keep in mind that these relate to a single batch prepared by the laboratory. It should not raise concerns about all the medicines available on the market.
As India’s pharmaceutical ecosystem continues to grow, consistent sample medicine testing, strict regulatory protocols, and standard lab practices will remain essential to ensure drug safety and maintain trust in the nation’s healthcare system.
